$8.33
2.2837.69%
Pre-Market: Apr 29, 5:32 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Cyclacel Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.